A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2006
12/06/2006	CN1872348A Ligand of polyoxyethylene of containing target peptide toward to liver cancer
12/06/2006	CN1872347A Cell preparation capable of excreting chalone of endothelium, and application for preparing medicine for treating tumour
12/06/2006	CN1872345A Gene synthetic approach for treating tumor (cancer)
12/06/2006	CN1872344A Gene therapy method of stem cell (carrying therapy gene) of human xenogenic stroma
12/06/2006	CN1872343A Technique for preparing embolism agent of granule of polyvinyl alcohol
12/06/2006	CN1872342A Process for preparation of granular oral composition using oligosaccharide solution
12/06/2006	CN1872340A Genic bacterin for preventing and / or treating cancer
12/06/2006	CN1872336A Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
12/06/2006	CN1872334A Slow releasing microsphere preparation of Thymopentin, and prepartion method
12/06/2006	CN1872324A Medication for treating hysteromyoma
12/06/2006	CN1872299A Oral liquid for preventing cancer
12/06/2006	CN1872284A Chinese traditional medicine for treating breast cancer
12/06/2006	CN1872256A Method for preparing medical capsule for treating cancer of uterus, cervical carcinoma
12/06/2006	CN1872201A Receipt of 'Qingkailing' injection of containing vermilion and/or realgar, and preparing technique
12/06/2006	CN1872181A External use embrocation of Chinese traditional medicine for against cancer and stopping pain
12/06/2006	CN1872172A Polyphenol-enriched composition from cocoa shell extraction
12/06/2006	CN1872159A Application of red sage root in preparing medication for preventing prostatic csarcinoma from occurring
12/06/2006	CN1872117A Medication composition of replenishing qi to invigorate the spleen, preparation method and usage
12/06/2006	CN1872112A Drop pills of total saponin of gen-seng haulms, and preparation method
12/06/2006	CN1872107A Chinese and Western compound preparations of alpha receptor blocking pharmacon, preparation method, and application
12/06/2006	CN1872096A Medication for treating liver disease, and preparation method
12/06/2006	CN1872090A Freeze-dry powder injection preparation of Huachansu, and preparation technique
12/06/2006	CN1872076A Drop pills of cucurbitacine, and preparation method
12/06/2006	CN1872049A Combination of erigeron breviscapus and medication of chemotherapy in platinum class
12/06/2006	CN1872047A Application of erigeron breviscapus and Scutellarin in preparing medication anti tumor
12/06/2006	CN1872043A Application of salvianolic acid B in preparing medication for preventing tumorigenesis
12/06/2006	CN1872041A Medicine use of 3 ú¿3 nitryl 4 hydroxyú®- ethyl acrylate controlled xanthine oxidase
12/06/2006	CN1872031A Osmotic pump controlled release tablet of solid dispersion of hydroxy camptothecin and prepn. method
12/06/2006	CN1872030A Drop pills of anticancer drugs, and preparation method
12/06/2006	CN1872028A Immune magnetic Nano microsphere, preparation method, and application
12/06/2006	CN1288243C PEG-modified uricase
12/06/2006	CN1288170C Sulphatization derivative of polysaccharide, its preparation method and use
12/06/2006	CN1288166C Modified tumor antigen peptide and use thereof
12/06/2006	CN1288162C Process for extraction refining amygdalin
12/06/2006	CN1288153C Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible NO-synthase
12/06/2006	CN1288150C Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases
12/06/2006	CN1288148C 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
12/06/2006	CN1288137C 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone
12/06/2006	CN1287862C Method for MG 7-Ag analogue epitope to construct stomack cancer specific poly epitope gene vaccine
12/06/2006	CN1287859C Magnetic targeted carrier composed of iron and porous materials for targeted delivery of biologically active agents
12/06/2006	CN1287857C Method for preparing specific nano vaccine for stomach cancer
12/06/2006	CN1287853C Treatment of follicular lymphomas using inhibitors of the lymphotoxin (LT) pathway
12/06/2006	CN1287841C Method for preparing anti-cancer traditional Chinese medicine containing Mingri leaf
12/06/2006	CN1287814C Extractive originated from cedrela sinensis, its preparation process and usage
12/06/2006	CN1287809C Method of extracting total flavone product from halenalin plant full flower
12/06/2006	CN1287804C Suspension of Fe#-[3]O#-[4] microparticle and iodized oil for treating liver and kidney tumor by embolizing and its preparation process
12/06/2006	CN1287802C Process for preparing lentinan drip liquid
12/06/2006	CN1287796C Composition of epigallocatechin, gallate and folic acid and its use in preparation of medicine
12/06/2006	CN1287794C Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
12/06/2006	CN1287778C Use of N,N-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer therapy
12/06/2006	CN1287773C Medicinal preparation containing brucea fruit oil
12/06/2006	CA2549663A1 Endoribonuclease and uses thereof
12/05/2006	USRE39419 Estrogen agonist/antagonist metabolites
12/05/2006	US7145025 Structural carotenoid analogs for the inhibition and amelioration of disease
12/05/2006	US7145008 Pyrimidine derivatives for the treatment of abnormal cell growth
12/05/2006	US7144918 Enzyme inhibitors; anticancer agents
12/05/2006	US7144917 For therapy and prophylaxis of cancer, angiogenesis, arthritis, connective tissue disease, cardiovascular disease, inflammation or autoimmune disease in a mammal
12/05/2006	US7144912 drugs such as (4-methoxy-5-(1H-indol-2yl-methylene)-2,2'-bi-1H-pyrrole) used as anticarcinogenic or antitumor agents
12/05/2006	US7144902 Prodrugs of thrombin inhibitors
12/05/2006	US7144893 4-aryl quinols and analogs thereof as therapeutic agents
12/05/2006	US7144891 derivatives of acronycine such as cis-2-cinnamoyloxy-1-hydroxy-6-methoxy-3,3,14-trimethyl-1,2,3,14-tetrahydro-1H-benzo[b]pyrano[3,2-h]acridin-7-one, used as antitumor agents
12/05/2006	US7144882 Central nervous system disorders; psychological disorders; inflammatory bowel disorders
12/05/2006	US7144879 Substituted metal-phthalocyanines, their preparation and the use thereof
12/05/2006	US7144873 Therapy for anticancer agents, blood disorders; dissolving in nonaqueous solvent
12/05/2006	US7144870 Gene therapy; lyases; hyaluronidase; anticancer agents (retinoblastomas); kits
12/05/2006	US7144586 Compositions for preventing hormone induced adverse effects
12/05/2006	CA2396458C Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
12/05/2006	CA2384929C A novel angiogenesis inhibitor
12/05/2006	CA2293713C Bispyrido-cycloheptane compounds useful for inhibition of farnesyl protein transferase
12/05/2006	CA2215067C Use of betulinic acid and its derivatives for inhibiting malignant melanoma growth and a method of monitoring this
12/05/2006	CA2176604C Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin
12/05/2006	CA2150382C Process for the preparation of 9-amino camptothecin
12/05/2006	CA2146429C 25-carboxylic acid derivatives in the vitamin d series, method of producing them, intermediate products for this method, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines
11/2006
11/30/2006	WO2006128063A2 Methods and compositions for inhibiting glioma growth
11/30/2006	WO2006127909A2 Polymorphic forms of (s)-1-cyanobutan-2-yl (s)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) phenyl) ethylcarbamate
11/30/2006	WO2006127587A1 Pyrrolopyridines useful as inhibitors of protein kinase
11/30/2006	WO2006127364A1 Apoptosis promoters
11/30/2006	WO2006127207A1 Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof
11/30/2006	WO2006126514A1 Arylacetate derivative having isoxazole skeleton
11/30/2006	WO2006126505A1 Stat function inhibitor and application thereof
11/30/2006	WO2006126488A1 Cauliflower mushroom extract
11/30/2006	WO2006126067A1 A pharmaceutical composition useful for the treatment of hepatocellular carcinoma
11/30/2006	WO2006125921A2 Antibody or antibody fragment coupled with an immunogenic agent
11/30/2006	WO2006125640A2 Generation and profiling of fully human hucal gold®-derived therapeutic antibodies specific for human cd38
11/30/2006	WO2006125555A2 Quinazolinones
11/30/2006	WO2006125540A1 Combination therapy comprising a diaryl urea compound and a pi3, akt kinase or mtor inhibitors (rapamycins) for cancer treatment
11/30/2006	WO2006125539A2 Combination therapy comprising diaryl ureas for treating diseases
11/30/2006	WO2006125531A2 Thienopyridines
11/30/2006	WO2006125381A1 Tumor targeting gene-virus zd55-il-24, construction method and application thereof
11/30/2006	WO2006125293A1 Derivatives of 4- or 5-aminosalicylic acid
11/30/2006	WO2006061715A3 Methylene inhibitors of matrix metalloproteinase
11/30/2006	WO2006034478A3 Isomigrastatin analogs in the treatment of cancer
11/30/2006	US20060270719 2-[(Cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-2-yl-benzyl)-amino]-N-hydroxy-acetamide; selective inhibitors of matrix-degrading metalloproteinases, especially MT1-MMP, MMP-2 and MMP-9; Osteoporosis; Antitumor, antiproliferative agents
11/30/2006	US20060270718 e.g. N-(4-{1-Hydroxy-1-[1-(2-methoxyethyl)-1H-pyrrol-2-yl]-ethyl}-phenyl)-N-methyl-benzenesulfonamide; liver X receptor (LXR) agonist; antidiabetic, antiproliferative agent; lipid, metabolic disorders, obesity, diabetes, hypercholesterolemia, atherosclerosis, hyperlipoproteinemia
11/30/2006	US20060270692 2-(4-{[7-(3-chloropropoxy)-6-methoxyquinazolin-4-yl]amino}-1H-pyrazol-1-yl)-N-(3-fluorophenyl)acetamide; colorectal cancer
11/30/2006	US20060270689 Novel Fused Heterocycles and Uses Thereof
11/30/2006	US20060270687 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states
11/30/2006	US20060270681 Pyridazine derivatives
11/30/2006	US20060270679 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/30/2006	US20060270665 Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity

1 ... 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 ... 2211